• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Citrix Systems
CuriosityStream Inc. - Class A Common Stock
InnovAge Holding Corp. - Common Stock
Manulife Financial Corporation
Neovasc Inc. - Common Shares
PLAYSTUDIOS, Inc. - Warrant
Party City Holdco Inc. Common Stock
PattersonCompanies
SLR Investment Corp. - Closed End Fund
Satellos Bioscience Inc. - Common Stock
Standard BioTools Inc. - Common Stock
Swvl Holdings Corp - Ordinary Shares
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

402.38 +1.01 (+0.25%)
Delayed Quote Updated: 9:47 AM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,148
Open 399.94
Bid (Size) 401.49 (100)
Ask (Size) 403.28 (100)
Prev. Close 401.37
Today's Range 395.33 - 404.46
52wk Range 181.00 - 437.41
Shares Outstanding 139,693,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Natera (NTRA) Stock Is Up Today
October 19, 2026
What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA) jumped 2.4% in the afternoon session after the company announced that incorporating pha... 
Via StockStory
News headline image
ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
October 18, 2026
From Natera, Inc.
Via Business Wire

Performance

52-Week Range 8.0% below 52-week high
402.38
181.0052W Low 437.4152W High
1 Week 4.2% below 1-week high
383.761W Low 420.151W High

Natera, Inc. - Common Stock (NTRA) traded between $181.00 and $437.41 over the past 52 weeks and last traded at $402.38, 8.0% below its 52-week high. Over the past week it ranged between $383.76 and $420.15.

Past 12 Months
+2.3%
+2.9%
+52.0%
+100.1%
+75.8%
+114.0%
1W +$8.94
1M +$11.49
3M +$137.69
6M +$201.25
YTD +$173.54
1Y +$214.36

NTRA was +114.0% over the past year, +100.1% over six months, +75.8% year to date, +2.3% in the last week.

12 Months vs Market
NTRA
+114.0%
DIA
+12.2%
SPY
+13.9%
QQQ
+16.3%
IWM
+12.9%

Over the past 12 months NTRA returned +114.0% versus DIA (Dow) +12.2%, SPY (S&P 500) +13.9%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +12.9%.

Volume & Liquidity 0.03× 3-mo avg
Today 44,148 3-mo avg 1.5M
1W
1.4M
1M
1.7M
3M
1.5M
6M
1.5M
YTD
1.4M
1Y
1.4M

NTRA most recently traded 44,148 shares against a 3-month average daily volume of 1.5M.

More News

Read More
News headline image
Natera’s Signatera™ MRD Test Named to TIME’s List of the Best Inventions of 2026
October 15, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
October 13, 2026
From Natera, Inc.
Via Business Wire
News headline image
Why Natera (NTRA) Stock Is Up Today
October 09, 2026
Via StockStory
News headline image
FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay
October 09, 2026
From Natera, Inc.
Via Business Wire
News headline image
3 Market-Beating Stocks with Competitive Advantages
October 08, 2026
Via StockStory
News headline image
Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
October 07, 2026
From Natera, Inc.
Via Business Wire
News headline image
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists
October 06, 2026
From Natera, Inc.
Via Business Wire
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges
October 06, 2026
Via StockStory
News headline image
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
October 05, 2026
From Natera, Inc.
Via Business Wire
News headline image
2 Growth Stocks to Stash and 1 That Underwhelm
October 05, 2026
Via StockStory
News headline image
1 Unprofitable Stock to Target This Week and 2 We Question
September 30, 2026
Via StockStory
News headline image
Stocks making big moves yesterday: AutoZone, Natera, Shopify, Twilio, and Lennar
September 23, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Why Is Natera (NTRA) Stock Soaring Today
September 22, 2026
Via StockStory
News headline image
Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
September 22, 2026
From Natera, Inc.
Via Business Wire
News headline image
Natera CEO Steven Chapman Sells 1,698 Shares for $545,000 ↗
September 18, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM
September 18, 2026
From Natera, Inc.
Via Business Wire
News headline image
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy? ↗
September 14, 2026
Via The Motley Fool
News headline image
3 Reasons Investors Love Natera (NTRA)
September 09, 2026
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia) ↗
September 08, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗
September 04, 2026
Via Benzinga
News headline image
New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma
September 01, 2026
From Natera, Inc.
Via Business Wire
News headline image
3 Momentum Stocks to Own for Decades
August 31, 2026
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run? ↗
August 29, 2026
Via The Motley Fool

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 402.38
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 10/23/26 09:47 AM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 56.21B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 56B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap